Share Buyback of 35,300 Shares | Mochida Pharmaceutical May 2026

Overview of Capital Policy

Mochida Pharmaceutical acquired 35,300 shares of treasury stock through market purchases from May 18 to May 31, 2026. The total acquisition amount was 124,315,000 yen, based on a resolution at the Board of Directors meeting on March 30, 2026, which planned to acquire up to 530,000 shares (1.50% of issued shares). This acquisition was part of that plan, and while some or all of the purchases could have been withheld depending on market conditions, the acquisitions were successfully completed.

Impact on Shareholders and Future Outlook

This share buyback aims to limit dilution of issued shares and strengthen shareholder returns. Moving forward, the company intends to continue pursuing share repurchases and dividend policies as part of its capital policy to enhance shareholder value. Additional purchases or capital measures may be considered depending on market trends and performance.